Whalesbook
Financial Turnaround and Strategic Overhaul at SastaSundar Ventures
SastaSundar Ventures Limited is charting a new course with a strong financial showing in the third quarter of fiscal year 2026 (Q3 FY'26) and a significant strategic plan involving a merger and demerger. The company reported a 22% year-on-year (YoY) increase in Revenue from Operations to ₹341 crore for Q3 FY'26. Crucially, its Gross Profit jumped by 55% YoY, leading to an expansion in Gross Margin to 7.6% from 6% in the same period last year. This operational efficiency translated into a narrowed EBITDA loss of ₹14 crore, a 41% improvement YoY, with the EBITDA margin also seeing a 4% YoY enhancement. The company also achieved a turnaround in its EBIT, reporting a profit of ₹1 crore against a loss of ₹37 crore in Q3 FY'25.
For the nine-month period of FY'26 (9M FY'26), the financial narrative continued positively. Revenue grew 15% YoY to approximately ₹928 crore, while Gross Profit rose 30% YoY. The PAT for 9M FY'26 stood at ₹11 crore, a stark contrast to the ₹151 crore loss recorded in the prior year's corresponding period.
Future Growth Drivers and Restructuring
The company has laid out ambitious growth strategies. Its B2B platform, 'Retailer Shakti,' is on track for EBITDA break-even by Q4 FY'26 and is projected to deliver sustainable profitability from FY'27. The B2C platform, 'SastaSundar B2C,' aims for contribution margin positivity in FY'27. Significant investments are being channelled into AI-enabled technology to enhance customer experience, supply chain efficiency, and personalization, with these benefits expected from FY'27 onwards.
A major strategic move is the planned merger and demerger, slated for completion in FY'27. This will create two distinct listed entities: 'Health X Platform Limited' focused on healthcare, and 'Microsec Resources,' an NBFC. Post-restructuring, SastaSundar Ventures Limited will be renamed 'Health X Platform Limited,' absorbing SastaSundar and HealthBuddy. The NBFC business will be demerged and listed separately. Promoters are expected to hold a significant stake in both entities, with Rohto Pharmaceutical holding around 16% in the merged healthcare arm.
Further initiatives include the launch of the 'JITO' private label brand to leverage its network of ~65,000 retail pharmacies, targeting 10% of revenue contribution in 3-4 years. The 'Retailer Shakti' platform has a projected CAGR of over 30% for the next decade. An AI-driven SaaS platform for retailers, 'Retail Air,' is also planned for launch within 3-4 months.
Financial Prudence and Outlook
Management highlighted a commitment to capital efficiency, with planned future investments in technology funded by treasury income, which stands at approximately ₹500 crore at the company level. The total investment in building core IPs for its platforms has been around ₹83 crore. The company aims to achieve negative working capital within 3-4 years, reducing inventory days from the current ~21-22 days. The outlook is optimistic, with SastaSundar B2C expected to regain its previous scale within a year, and 'Retailer Shakti' projected to become PAT positive in FY'27.
Risks and Governance
While the financial performance shows a positive trajectory, key risks include the successful execution of the complex merger and demerger process, intense competition in both the e-pharmacy and NBFC spaces, and the ability to achieve aggressive profitability targets for its platforms. The company's stated goal of negative working capital requires significant operational discipline. Based on available public information, there are no widespread reports of major fraud, SEBI penalties, or significant governance issues that are currently material to this specific financial update.
Peer Comparison
In the online pharmacy space, SastaSundar Ventures competes with players like Tata 1mg, PharmEasy, and Netmeds. These competitors have also been investing heavily in technology and expanding their reach. Tata 1mg, backed by Tata Digital, and PharmEasy have been consolidating their positions through acquisitions and platform integration. The NBFC sector, where 'Microsec Resources' will operate, is highly competitive, with established players and new entrants vying for market share. The success of SastaSundar's restructuring will depend on how effectively each new entity can carve out its niche and compete within its respective industry.
This report is based on the company's earnings call held on February 9, 2026.